IP Rights, Benefit Sharing And R&D Dominate Talks On WHO Pandemic Treaty
Executive Summary
A lot of work needs to be done, and many compromises struck, if talks on the proposed pandemic accord are to be completed in time for the May 2024 deadline.
You may also be interested in...
EU Critical Medicines List To Be Ready ‘Within Days’
Members of the European Parliament were told that once the list was out, work would begin on identifying the products most vulnerable to supply chain problems.
Controversial EU Study On Pharma Innovation & Access Sees The Light Of Day
Members of the European Parliament committee charged with leading the negotiations on the review of the EU pharmaceutical legislation have been presented with a study backing cuts in data protection and wider joint procurement of medicines outside emergency situations.
Bigger Trials, More RWE Needed for Future Crisis Response, Say EU Regulators
A report from the EU medicines regulatory network looks at what was done well in the response to the COVID-19 pandemic, and what needs to be improved if we are to be better prepared next time.